Drug
Continuous IV Infusion for 24 hr
Multiple cohorts
Healthy volunteers split by Gender and Age
Mild and moderate Renal impairment patients
Strict Study timeline
Start Cohort 1 within 3 days of 31-day IND wait complete;
Start each successive cohort within 2 weeks of previous cohort end
Study outcome
All primary and secondary objectives met; Sponsor planning to move the drug candidate to next stage
Study completed within the sponsor target timeline
